| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.0008 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.52 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |